Olaparib Receives Reimbursement for Advanced Pancreatic Cancer with BRCA Mutations The Italian Medicines Agency (AIFA) has approved the reimbursement of olaparib, a PARP inhibitor, for the maintenance treatment of patients …
Tag:
pancreatic
-
-
FDA Approves First-of-Its-Kind Device for Locally Advanced Pancreatic Cancer The U.S. Food and Drug Administration (FDA) has approved Optune Pax, a first-of-its-kind device for the treatment of adult patients with …